Ovascience Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
44,427.00
60,231.00
126,859.00
114,388.00
67,203.00
Other Current Assets
650.00
1,647.00
3,002.00
2,056.00
1,578.00
Total Current Assets
45,077.00
61,878.00
129,861.00
116,444.00
68,781.00
Net Property, Plant & Equipment
880.00
3,367.00
8,313.00
5,572.00
3,113.00
Total Investments and Advances
1,588.00
197.00
439.00
504.00
935.00
Other Assets
-
130.00
-
23.00
24.00
Total Assets
47,545.00
65,572.00
138,613.00
122,543.00
72,853.00
Accounts Payable
1,654.00
-
3,352.00
2,183.00
2,242.00
Other Current Liabilities
4,120.00
10,174.00
7,891.00
11,026.00
5,562.00
Total Current Liabilities
5,774.00
10,174.00
11,243.00
13,209.00
7,804.00
Other Liabilities
70.00
73.00
520.00
1,116.00
751.00
Total Liabilities
5,844.00
10,247.00
11,763.00
14,325.00
8,555.00
Common Equity (Total)
41,701.00
55,325.00
126,850.00
108,218.00
64,298.00
Total Shareholders' Equity
41,701.00
55,325.00
126,850.00
108,218.00
64,298.00
Total Equity
41,701.00
55,325.00
126,850.00
108,218.00
64,298.00
Liabilities & Shareholders' Equity
47,545.00
65,572.00
138,613.00
122,543.00
72,853.00

About Ovascience

View Profile
Address
9 Fourth Avenue
Waltham Massachusetts 02451
United States
Employees -
Website http://www.ovascience.com
Updated 09/14/2018
OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H.